company background image
A258540 logo

SL Therapeutics XKON:A258540 Stock Report

Last Price

₩600.00

Market Cap

₩3.3b

7D

-21.8%

1Y

-70.0%

Updated

20 Mar, 2024

Data

Company Financials

SL Therapeutics, Inc.

XKON:A258540 Stock Report

Market Cap: ₩3.3b

A258540 Stock Overview

SL Therapeutics Inc. engages in cell therapy and medical device businesses.

A258540 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

SL Therapeutics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SL Therapeutics
Historical stock prices
Current Share Price₩600.00
52 Week High₩2,300.00
52 Week Low₩376.00
Beta0
1 Month Change-31.51%
3 Month Change2.04%
1 Year Change-69.99%
3 Year Change-90.32%
5 Year Change-91.00%
Change since IPO-86.96%

Recent News & Updates

Recent updates

Shareholder Returns

A258540KR Life SciencesKR Market
7D-21.8%2.5%0.02%
1Y-70.0%6.5%11.3%

Return vs Industry: A258540 underperformed the KR Life Sciences industry which returned 6.5% over the past year.

Return vs Market: A258540 underperformed the KR Market which returned 11.3% over the past year.

Price Volatility

Is A258540's price volatile compared to industry and market?
A258540 volatility
A258540 Average Weekly Movement15.2%
Life Sciences Industry Average Movement6.6%
Market Average Movement5.2%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A258540's share price has been volatile over the past 3 months.

Volatility Over Time: A258540's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2011n/aJong Sung Choihttps://www.stemlab.co.kr

SL Therapeutics Inc. engages in cell therapy and medical device businesses. The company develops cell therapeutic solutions based on its cell reprogramming technology to treat various diseases with a focus on spinal cord injury, and age and genetically related diseases; and hair follicle cells, skin cells, and cells of the central nervous system. It also manufactures automated magnetic resonance imaging systems; and Supra Elite and Dexino bone mineral density measurement devices.

SL Therapeutics, Inc. Fundamentals Summary

How do SL Therapeutics's earnings and revenue compare to its market cap?
A258540 fundamental statistics
Market cap₩3.28b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A258540 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A258540 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.